Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Patients”

560 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 560 results

Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableUnknownNCT02612402
What this trial is testing

Effect of Smartphone App on Activity

Who this might be right for
Diabetes Type 2Hematologic Malignancy
Rambam Health Care Campus 270
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Not applicableStudy completedNCT06936007
What this trial is testing

Hematological Manifestations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Patan Academy of Health Sciences 99
Not applicableNot Yet RecruitingNCT06402175
What this trial is testing

Characteristics and Outcomes of Patients With Hematological Malignancies

Who this might be right for
Haematologic Neoplasm
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT00866762
What this trial is testing

The Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Copenhagen University Hospital at Herlev 60
Not applicableUnknownNCT05780411
What this trial is testing

Cancer Survivorship in Hematologic Malignancies

Who this might be right for
Cancer Survivors
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT01816230
What this trial is testing

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+1 more
Gamida Cell ltd 36
Early research (Phase 1)UnknownNCT00688116
What this trial is testing

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Synta Pharmaceuticals Corp. 45
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Not applicableNot Yet RecruitingNCT07559032
What this trial is testing

Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients

Who this might be right for
Invasive Fungal Disease
Peking University People's Hospital 15
Not applicableLooking for participantsNCT06829654
What this trial is testing

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

Who this might be right for
SarcomasHaematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Large-scale testing (Phase 3)Ended earlyNCT01820962
What this trial is testing

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Who this might be right for
Hematological MalignanciesBacteremiaThrombosis
Maastricht University Medical Center 212
Testing effectiveness (Phase 2)Active Not RecruitingNCT05428969
What this trial is testing

Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Faron Pharmaceuticals Ltd 181
Post-approval studies (Phase 4)Study completedNCT01856803
What this trial is testing

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Who this might be right for
Leukemia, GVHD, ATG, Transplantation
Peking University People's Hospital 300
Not applicableStudy completedNCT04888286
What this trial is testing

DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 912
Early research (Phase 1)Study completedNCT01551524
What this trial is testing

Phase I Study of mPEG-R-Crisantaspase Given IV

Who this might be right for
Hematologic Malignancies
Jazz Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Next Page